APA (7th ed.) Citation

Zomer, E., Si, S., Hird, T., Liew, D., Owen, A., Tonkin, A., . . . Ademi, Z. (2018). Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective. Sage Publications.

Chicago Style (17th ed.) Citation

Zomer, E., S. Si, T. Hird, D. Liew, A. Owen, A. Tonkin, Christopher Reid, and Z. Ademi. Cost-effectiveness of Low-dose Rivaroxaban and Aspirin Versus Aspirin Alone in People with Peripheral or Carotid Artery Disease: An Australian Healthcare Perspective. Sage Publications, 2018.

MLA (9th ed.) Citation

Zomer, E., et al. Cost-effectiveness of Low-dose Rivaroxaban and Aspirin Versus Aspirin Alone in People with Peripheral or Carotid Artery Disease: An Australian Healthcare Perspective. Sage Publications, 2018.